The amount of weight loss achieved in our trial — namely, a mean of 3.2 kg (7.0 lb) at 18 months — compares favorably with weight loss in lifestyle-intervention trials in the general population. This extent of weight loss, albeit modest, has been shown to have beneficial effects, such as a reduced risk of cardiovascular disease among persons with an initially elevated risk